Phase I study of CC-486 alone and in combination with carboplatin or nab-paclitaxel in patients with relapsed or refractory solid tumors

  1. Von Hoff, D.D.
  2. Rasco, D.W.
  3. Heath, E.I.
  4. Munster, P.N.
  5. Schellens, J.H.M.
  6. Isambert, N.
  7. Le Tourneau, C.
  8. O'Neil, B.
  9. Mathijssen, R.H.J.
  10. Lopez-Martin, J.A.
  11. Jeff Edenfield, W.
  12. Martin, M.
  13. LoRusso, P.M.
  14. Bray, G.L.
  15. DiMartino, J.
  16. Nguyen, A.
  17. Liu, K.
  18. Laille, E.
  19. Bendell, J.C.
Revista:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Any de publicació: 2018

Volum: 24

Número: 17

Pàgines: 4072-4080

Tipus: Article

DOI: 10.1158/1078-0432.CCR-17-3716 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus